News ArticleApollo Hospitals Finalizes Sale of Subsidiaries to Kids Clinic India, Acquires 9.9% Stake in KCIL
Transaction valued at approx Rs 9,500 million completed on November 3, 2026, including Rs 7,650 million cash and equity shares
Apollo Hospitals Enterprise Limited has completed the divestment of its subsidiaries Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited, receiving Rs 7,650 million in cash and acquiring an effective 9.9% equity stake in KCIL, marking a significant shareholding update.
Apollo Hospitals Enterprise Limited
Financial Results
Apollo Hospitals Enterprise Limited has completed the sale of its subsidiaries Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited, receiving cash consideration and gaining an equity stake in KCIL.
The transaction closed on November 3, 2026, with Apollo Health and Lifestyle Limited, a wholly owned subsidiary of Apollo Hospitals, receiving cash consideration of Rs 7,650 million and an effective 9.9% equity stake in Kids Clinic India Limited valued at Rs 1,850 million.
This divestment means that Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited have ceased to be subsidiaries of Apollo Health and Lifestyle Limited.
The overall enterprise value of the transaction was approximately Rs 9,500 million.
Apollo Hospitals also announced leadership changes, including the cessation of Dr. Madhu Sasidhar from the position of President & CEO - Hospitals Division effective November 14, 2026.
The Board approved unaudited consolidated and standalone financial results for the three and six months ended September 30, 2026, which have been subject to limited review by statutory auditors.
Highlights
- Divestment completed on November 3, 2026.
- Transaction enterprise value approximately Rs 9,500 million.
- Cash consideration of Rs 7,650 million received.
- Apollo Health and Lifestyle Limited allotted securities representing an effective 9.9% equity stake in Kids Clinic India Limited.
- Dr. Madhu Sasidhar to step down as President & CEO - Hospitals Division effective November 14, 2026.
- Unaudited financial results for Q2 and H1 FY 2026-27 approved by the Board.
Key Data Snapshot
What happened
- Apollo Hospitals Enterprise Limited completed the divestment of its wholly owned subsidiaries Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited.
- Transaction closed on November 3, 2026, involving cash payment and allotment of shares.
- Apollo Health and Lifestyle Limited received Rs 7,650 million in cash and securities representing approximately 9.9% equity stake in Kids Clinic India Limited.
- The divested entities ceased to be subsidiaries of Apollo Health and Lifestyle Limited post transaction.
Key details
- The total enterprise value of the transaction was approximately Rs 9,500 million.
- The equity stake in Kids Clinic India Limited was valued at Rs 1,850 million.
- Leadership change includes cessation of Dr. Madhu Sasidhar as President & CEO - Hospitals Division effective November 14, 2026.
- The Board approved unaudited standalone and consolidated financial results for the three and six months ended September 30, 2026.
Regulatory and governance context
- The transaction and leadership changes were disclosed in compliance with SEBI Listing Regulations and applicable circulars.
- The unaudited financial results have been subjected to limited review by statutory auditors and will be published in newspapers as per SEBI regulations.
- The Board appointed new senior management personnel to maintain business continuity post leadership changes.
Highlights
- Divestment completed on November 3, 2026.
- Transaction enterprise value approximately Rs 9,500 million.
- Cash consideration of Rs 7,650 million received.
- Apollo Health and Lifestyle Limited allotted securities representing an effective 9.9% equity stake in Kids Clinic India Limited.
- Dr. Madhu Sasidhar to step down as President & CEO - Hospitals Division effective November 14, 2026.
- Unaudited financial results for Q2 and H1 FY 2026-27 approved by the Board.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Tube Investments of India Posts Rs. 346.74 Crore Profit After Tax for Q2 2026 and Approves Rs. 83 Crore Capacity Expansion in Cold Rolled Steel
Tube Investments of India Limited reported a profit after tax of Rs. 346.74 crore for the quarter ended September 30, 2026, and approved an Rs. 83 crore capital expenditure to enhance Cold Rolled Steel Strips manufacturing capacity at its Avadi facility, expected to complete in fiscal year 2027-28.
Read Full Story
Sundaram Finance Announces Q2 and Half-Year FY2026-27 Results with Standalone PAT of ₹822.92 Crores and Consolidated PAT of ₹1,426.28 Crores
Sundaram Finance Limited released its unaudited standalone and consolidated financial results for the quarter and half-year ended 30 September 2026. The standalone profit after tax (PAT) stood at ₹822.92 crores for the quarter, while the consolidated PAT was ₹1,426.28 crores for the half-year period.
Read Full Story
Ipca Laboratories Records Rs 1,049.12 Crores Profit Before Tax and Rs 7,336.75 Crores Revenue for H1 FY27
Ipca Laboratories Limited announced its unaudited standalone financial results for Q2 and H1 FY27, reporting total income of Rs 7,336.75 crores and profit before tax of Rs 1,049.12 crores for the half year ended September 30, 2026.
Read Full Story
